BiotechTube
Home/Pipeline/Multi‑Cancer Screening Test (MCST)

Multi‑Cancer Screening Test (MCST)

Pan‑cancer early detection

Phase 2Active

Key Facts

Indication
Pan‑cancer early detection
Phase
Phase 2
Status
Active
Company
MiRXES

About MiRXES

RNA‑based diagnostics company delivering early‑cancer blood tests and NGS tissue profiling.

View full company profile

Therapeutic Areas

OncologyInfectious Diseases